Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
6.57
-0.52 (-7.33%)
At close: Nov 7, 2025, 4:00 PM EST
6.58
+0.01 (0.15%)
After-hours: Nov 7, 2025, 4:00 PM EST
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $284.12 million as of November 7, 2025. Its market cap has increased by 26.64% in one year.
Market Cap
284.12M
Enterprise Value
100.85M
1-Year Change
26.64%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $284.12M, a decrease of -68.36%. That is a compound annual growth rate of -48.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 306.61M | 89.90% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 847.05B |
| Johnson & Johnson | 448.92B |
| AbbVie | 376.45B |
| UnitedHealth Group | 295.07B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 216.39B |
| Novo Nordisk | 215.64B |